BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 384.71M | 237.01M | 227.36M | 66.50M | 124.84M |
| Total Depreciation and Amortization | 37.34M | 38.92M | 39.40M | 34.44M | 35.75M |
| Total Amortization of Deferred Charges | 23.60M | 1.59M | 1.74M | 1.55M | 1.54M |
| Total Other Non-Cash Items | 132.30M | 115.55M | 121.98M | 151.31M | 140.41M |
| Change in Net Operating Assets | -69.23M | 69.75M | -189.14M | 163.55M | 100.02M |
| Cash from Operations | 508.71M | 462.82M | 201.34M | 417.35M | 402.55M |
| Capital Expenditure | -35.18M | -27.48M | -40.79M | -37.52M | -48.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -585.00K | -21.88M | -4.72M | -813.00K | -1.19M |
| Cash from Investing | -35.76M | -49.35M | -45.51M | -38.34M | -49.27M |
| Total Debt Issued | 0.00 | 0.00 | 58.20M | 862.74M | 0.00 |
| Total Debt Repaid | -7.84M | -17.05M | -7.64M | -783.62M | -4.26M |
| Issuance of Common Stock | 110.08M | 11.05M | 23.88M | 19.24M | 80.54M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -50.00K | -5.81M | -1.44M | 885.00M |
| Cash from Financing | 102.19M | -6.05M | 68.63M | 96.93M | 961.27M |
| Foreign Exchange rate Adjustments | 10.50M | 19.84M | 19.32M | 23.16M | 9.91M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 585.64M | 427.25M | 243.78M | 499.11M | 1.32B |